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Abstract
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This research examined optimism’s relationship with total cholesterol, high density lipoprotein
(HDL) cholesterol, low density lipoprotein (LDL) cholesterol, and triglycerides. The hypothesis
that optimism is associated with a healthier lipid profile was tested. Participants were 990 mostly
white men and women from the Midlife in the United States study who were on average 55.1
years old. Optimism was assessed by self-report with the Life Orientation Test. A fasting blood
sample was used to assess serum lipid levels. Linear and logistic regression models examined the
cross-sectional association between optimism and lipids accounting for covariates such as
demographic characteristics (e.g., education) and health status (e.g., chronic medical conditions).
After adjusting for covariates, results suggested that greater optimism was associated with higher
HDL cholesterol and lower triglycerides. Optimism was not associated with LDL or total
cholesterol. Findings were robust to a variety of modeling strategies that took into consideration
the effect of treatment for cholesterol problems. Results further indicated that diet and body mass
index may link optimism with lipids. In conclusion, this is the first study to suggest that optimism
is associated with a healthy lipid profile; moreover, these associations may be explained, in part,
by having healthier behaviors and a lower body mass index.
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INTRODUCTION
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This study investigated a cardiovascular risk factor that has yet to be empirically
investigated in relation to optimism – namely, serum lipids. Optimism and lipids were
expected to be associated because lipid profiles are driven in part by health behaviors and
optimism is linked with healthier behaviors such as eating a balanced diet, exercising, and
consuming moderate amounts of alcohol.1–4 We hypothesized that higher levels of optimism
would be associated with a healthier lipid profile (i.e., more high density lipoprotein [HDL]
cholesterol and less total cholesterol, low density lipoprotein [LDL] cholesterol, and
triglycerides), controlling for potential confounders (i.e., demographic characteristics and
health status). Moreover, we hypothesized that the association between optimism and lipid
levels would be partially explained by health behaviors such as moderate alcohol
consumption, exercise, diet, and the absence of cigarette smoking. To investigate these
hypotheses, we conducted cross-sectional analyses in men and women from the Midlife in
the United States (MIDUS) study.

METHODS

NIH-PA Author Manuscript
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The MIDUS study was started in 1995 to better understand connections between
psychosocial factors, aging, and health in men and women ages 25–74 years. More than
4,000 individuals were first recruited either by random digit dialing or by oversampling
select metropolitan areas.5 Twin pairs and 1 or more siblings of randomly selected
participants were recruited when possible, resulting in a total baseline sample of 7,108. A
longitudinal follow-up comprised of 5 distinct projects was initiated 9–10 years later. The
current investigation was based on a subsample of respondents from the longitudinal followup who completed the psychosocial project and the biomarker project. The psychosocial
project – which entailed a phone interview and self-administered questionnaires – was
completed by 5,895 of the original 7,108 participants and included measures of optimism
and demographic factors. Participants who completed the psychosocial project and who
were healthy enough to travel to a research clinic were eligible for the biomarker project,
which was conducted an average of 26 months later (standard deviation [SD] = 14.66; range
2 to 62 months). The biomarker project was an in-depth, multiday assessment with an
overnight stay that yielded measures of lipids, health status, and health behaviors, among
other things. Due to the substantial commitment required, 39.3% (n = 1,255) of 3,191
eligible men and women participated (43.1% participated after adjusting for those who could
not be contacted or located).6 Of eligible participants, those who participated in the
biomarker project did not differ from those who did not with regard to age, sex, race, marital
status, income, chronic disease, or body mass index (BMI), but they were more highly
educated.6 Only participants with complete data on optimism, lipid levels, potential
confounders, and pathway variables were included, yielding an analytic sample of 990. This
research was approved by the appropriate institutional review boards and participants
provided consent.
The 6-item Life Orientation Test-Revised was used to assess optimism.7 Participants
indicated the extent to which they agreed (1= agree a lot to 5 = disagree a lot) with 3
positively-worded items (“I expect more good things to happen to me than bad,” “I’m
always optimistic about my future,” “In uncertain times I usually expect the best”) and 3
negatively-worded items (“I hardly ever expect things to go my way,” “If something can go
wrong for me it will,” “I rarely count on good things happening to me”). Because optimism
may best be characterized by endorsing both positively-worded items and rejecting
negatively-worded items,8 we followed recommendations to use the 6-item composite rather
than the 3-item subscales.9 Positively-worded items were reverse scored and added to
negatively-worded items to create a total optimism score ranging from 6–30 (Figure 1; α =
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0.82). Higher values indicated more optimism and the total score was standardized (mean
[M] = 0, SD = 1) for greater interpretability.

NIH-PA Author Manuscript

Participants traveled to 1 of 3 clinical research sites for 2 days of biological assessment. On
the second morning of the visit, participants provided a fasting blood sample for a lipid
panel (in mg/dL) of total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides.
Samples were initially stored in a −60° C to −80° C freezer at each site and then frozen
serum (1 mL aliquots) was shipped on dry ice to Meriter Laboratories in Madison,
Wisconsin and stored in a −65° C freezer. All assays were performed with a Cobas Integra®
analyzer (Roche Diagnostics, Indianapolis, Indiana). An enzymatic colorimetric assay was
used for total cholesterol, HDL cholesterol, and triglycerides; LDL cholesterol was derived
with the Friedewald calculation10 (if triglyceride levels were >400 mg/dL, observed values
were replaced with 400 mg/dL for calculating LDL cholesterol). From the total biomarker
project sample, total cholesterol assays ranged from 0–800 mg/dL (reference range <200
mg/dL); the inter-assay coefficient of variation (CV) was 1.4–1.9% and intra-assay CV was
0.5–0.8%. HDL cholesterol assays ranged from 0–155 mg/dL (reference range 40–85 mg/
dL); the inter-assay CV was 2.2–2.3% and intra-assay CV was 1.1–1.5%. Triglycerides
assays ranged from 0–875 mg/dL (reference range <150 mg/dL); the inter-assay CV was
1.9% and intra-assay CV was 1.6%. The LDL cholesterol inter-assay CV was 10.11%
(reference range 60–129 mg/dL).

NIH-PA Author Manuscript

Analyses controlled for factors known to be associated with lipid profiles. Demographics
were self-reported and included age (in years), sex, race (white, non-white), education (<
high school degree, high school degree, some college, ≥ college degree), household income,
and months between assessment of optimism and serum lipids. Health status included
chronic conditions (none, 1 condition or more) and blood pressure medication use (no, yes).
The presence of chronic conditions (heart disease, hypertension, stroke, or diabetes) was
assessed by the item “Have you ever had any of the following conditions or illnesses
diagnosed by a physician?” Medications related to corticosteroids and depression were also
considered, but were not included in final models because they were not associated with
lipids in age-adjusted regression analyses. Categorical variables were dummy-coded prior to
inclusion in the models.

NIH-PA Author Manuscript

To examine optimism’s independent effects from psychological ill-being, negative affect
was controlled in secondary analyses. Negative affect was assessed during the psychosocial
project using 5 items from a widely-used and psychometrically valid scale.11 Participants
indicated the extent to which they felt afraid, jittery, irritable, ashamed, and upset in the past
30 days (1 = none of the time to 5 = all of the time). Following prior work in MIDUS, an
average score was calculated if at least 1 item was rated; higher scores reflected more
negative affect.
Potential behavioral pathways included smoking status (current smoker, past smoker, never
smoker), average number of drinks consumed/day in the past month, regular exercise at least
3 times per week for 20 minutes (no, yes), and prudent diet. Smoking status and exercise
were dummy-coded for statistical analysis. For diet, participants indicated their consumption
of food categories during an average day or week. Consistent with previous research,12 a
prudent diet score was calculated by giving participants a point for consuming: 3 or more
servings/day of fruit and vegetables, 3 or more servings/day of whole grains, 1 or more
serving/week of fish, 1 or more serving/week of lean meat, no sugared beverages, 2 or fewer
servings/week of beef or high fat meat, and food at a fast food restaurant < once per week.
Scores ranged from 0 to 7 (M = 4.24, SD = 1.39); higher scores indicated healthier diet.
Because BMI is a product of health behaviors and genetics, we also investigated its potential
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role as a mediator. BMI (in standardized kg/m2) was measured by clinical staff during the
biological assessment.
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Statistical analyses were conducted in SAS 9.2. Given that treatment for cholesterol
problems may bias findings, past work has routinely excluded participants who are receiving
treatment. However, such an approach is not recommended because it discards relevant
information, reduces power, and biases parameter estimates.13 Thus, following previous
research, the lipid levels of those individuals who were taking cholesterol medicine (n =
284) were corrected for the typical effect of such treatment.14–16 That is, we increased levels
of total cholesterol by 20%, LDL cholesterol by 35%, and triglycerides by 15%; we
decreased levels of HDL cholesterol by 5%. Because the distribution of triglyceride scores
was skewed and kurtotic, triglyceride scores were log transformed. Total cholesterol, HDL
cholesterol, and LDL cholesterol had approximately normal distributions and were not
transformed.

NIH-PA Author Manuscript

Each lipid served as an outcome in a series of linear regression models. The minimallyadjusted model included demographics (age, sex, race, education, income, and time between
psychosocial and biological assessments) and optimism as predictors. A second
multivariable-adjusted model added health status (chronic conditions and blood pressure
medication) to the first model. Sensitivity analyses examined whether results differed when:
1) original lipid scores for all participants were maintained, regardless of the use of
cholesterol medication (an approach where associations may be biased due to treatment), 2)
participants taking cholesterol medication were excluded, and 3) use of cholesterol
medication was included as a covariate.
Additional models examined whether health behaviors and BMI were on the pathway
between optimism and lipids in minimally-adjusted models. However, because all data for
relevant covariates were cross-sectional we did not formally test mediation and acknowledge
that the direction of effects could be reversed. Instead, we examined how the regression
coefficient for optimism changed when it was the sole predictor versus when a potential
pathway variable was added to the model.17 When the regression coefficient for optimism
was reduced (as indicated by a change of 10% or more) with the addition of a potential
pathway variable, this suggested that the pathway variable partly explained optimism’s
association with lipids.

NIH-PA Author Manuscript

In secondary analyses, negative affect was controlled in minimally-adjusted models and also
used to stratify minimally-adjusted models. We also conducted logistic regression analyses
for each lipid to see if optimism was associated with the probability of being at high risk for
unhealthy lipid levels (defined as taking cholesterol medication, diagnosed by a physician as
having cholesterol problems, or exceeding conventional cut-points for having high [or in the
case of HDL cholesterol low] lipid levels). To account for the clustering of data due to
presence of sibling and twin pairs in the cohort, we also reran primary statistical analyses
with generalized estimating equations. When primary statistical analyses were conducted
with generalized estimating equations, results were nearly identical to those described. This
suggests that the presence of clustering in the analytic sample did not bias parameter
estimates or standard errors. In the interest of interpretability, we present findings from
primary statistical analyses. We also examined whether the association between optimism
and lipid levels differed by race, but no differences were evident so results are not presented.

RESULTS
Participants were on average 55.12 years of age (SD = 11.78), with a range from 34 to 84
years. Men comprised 45% of the sample (n = 449) and women comprised 55% of the
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sample (n = 541). The vast majority of the sample was white (93%; n = 923). Average lipid
levels were 196.62 mg/dL (SD = 38.00; 1st quartile = 171.00; 2nd quartile = 194.40; 3rd
quartile = 218.40) for total cholesterol, 54.08 mg/dL (SD = 17.63; 1st quartile = 41.00; 2nd
quartile = 51.64; 3rd quartile = 64.21) for HDL cholesterol, and 115.41 mg/dL (SD = 35.28;
1st quartile = 91.12; 2nd quartile = 111.75; 3rd quartile = 136.00) for LDL cholesterol. The
average value of triglycerides was 135.42 (SD = 82.12; 1st quartile = 81.00; 2nd quartile =
113.85; 3rd quartile = 166.00) prior to transformation. Tables 1–2 show the distribution of
covariates according to optimism level and correlations between optimism and covariates.
More optimistic individuals tended to be older, have higher levels of education and income,
engage in healthier behaviors, and report less negative affect compared with their less
optimistic peers.
Optimism was not associated with LDL cholesterol and total cholesterol, but was associated
with HDL cholesterol and triglycerides in the expected directions (Table 3). For each SD
increase in optimism, levels of HDL cholesterol were more than 1 mg/dL higher. For each
SD increase in optimism, levels of triglycerides were 3% lower. Findings were only
modestly attenuated after multivariable adjustment.
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When the original lipid scores were used without correcting for cholesterol treatment, results
were virtually identical to those that adjusted for the average effect of lipid medication (data
not shown). Similarly, when examining the association between optimism and lipids among
the 706 participants who were not taking cholesterol medication, results were mostly
indistinguishable. For example, among participants not taking cholesterol medication,
greater optimism was associated with higher levels of HDL cholesterol (b = 1.39, 95% CI
[0.15, 2.63], p = 0.03) and lower levels of triglycerides (b = −0.04, 95% CI [−0.08, 0.002], p
= 0.06) in minimally-adjusted models. Findings were also nearly identical in models that
controlled for cholesterol medication. For example, in minimally-adjusted models, HDL
cholesterol (b = 1.27, 95% CI [0.23, 2.31], p = 0.02) and triglycerides (b = −0.03, 95% CI
[−0.06, 0.003], p = 0.07) were still positively and inversely associated with optimism,
respectively. Consistent with the models that adjusted for the typical effect of medication,
LDL cholesterol and total cholesterol were not associated with optimism in any of the
sensitivity analyses. Thus, the association between optimism and lipid profiles was robust
regardless of cholesterol treatment.
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Because optimism was related to higher HDL cholesterol and lower triglycerides, we
examined whether the associations might be explained by health behaviors and BMI (Table
4). Prudent diet, smoking status, and BMI reduced the relationship between optimism and
HDL cholesterol by more than 10%. When all health behaviors and BMI were included in
the model simultaneously, the association between optimism and HDL cholesterol was
reduced by half and the effect of optimism was no longer statistically significant. Prudent
diet and BMI also reduced optimism’s association with triglycerides; when all pathway
variables were included in the model the association between optimism and triglycerides
was reduced by half.
When negative affect was included with optimism in minimally-adjusted models, previously
reported findings were slightly attenuated. Optimism remained associated with HDL
cholesterol (b = 1.28, 95% CI [0.13, 2.43], p = 0.03), but negative affect was not (b = −0.20,
95% CI [−2.48, 2.07], p = 0.86). Optimism was not associated with triglycerides, but
negative affect was (optimism: b = −0.01, 95% CI [−0.05, 0.02], p = 0.45; negative affect: b
= 0.09, 95% CI [0.02, 0.16], p = 0.02). Neither optimism nor negative affect were associated
with LDL cholesterol and total cholesterol. Furthermore, we also stratified these models by
negative affect such that 58% of the sample was classified as having lower levels of negative
affect and 42% of the sample was classified as having higher levels. Among participants
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with relatively lower levels of negative affect, optimism’s association with HDL cholesterol
(b = 2.66, 95% CI [1.05, 4.26], p = 0.001) and triglycerides (b = −0.07, 95% CI [−0.12,
−0.02], p = 0.009) paralleled primary findings. Associations among participants with
relatively more negative affect were not statistically significant. The interaction term
between optimism and negative affect was marginally significant for HDL cholesterol (p = .
06) and statistically significant for triglycerides (p = .009).
In analyses modeling risk of unhealthy lipid levels, patterns were generally consistent.
Controlling for confounding variables in minimally-adjusted and multivariable-adjusted
models, there was a 7–14% reduction in the odds of having unhealthy lipid levels for every
SD increase in optimism (Table 5). Findings were strongest for HDL cholesterol and
triglycerides.

DISCUSSION
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This study investigated the cross-sectional association between optimism and lipids.
Consistent with predictions, more optimistic attitudes were associated with higher HDL
cholesterol and lower triglycerides. Specifically, for every SD increase in optimism, HDL
cholesterol levels were 1 mg/dL higher and triglyceride levels were 3% lower. The size of
these associations is relatively small although clinically significant; for example, a 1 mg/dL
increase in HDL cholesterol is related to a 2–3% reduction in risk of coronary heart
disease.18 The magnitude of association between optimism and lipids is also comparable to
the association between these lipids and health behaviors such as physical activity. Metaanalyses show that exercising can improve levels of HDL cholesterol and triglycerides by 4–
6%19 or increase HDL cholesterol levels by 2.53 mg/dL.20 Moreover, even small
improvements at the individual level may translate into shifts in the distribution of risk at the
population level.21 Thus, our findings suggest that optimism may play a meaningful and
non-trivial role in healthy lipid profiles.
Optimism was not associated with total cholesterol or LDL cholesterol. Though it is unclear
why only HDL cholesterol and triglycerides were marginally or significantly related to
optimism, such findings are consistent with research on other psychosocial factors.22 For
example, the personality traits of conscientiousness and impulsivity were more consistently
associated with HDL cholesterol and triglycerides than LDL cholesterol or total
cholesterol.23
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Optimism’s association with HDL cholesterol and triglycerides was robust to alternative
modeling strategies. Results did not measurably change when lipid levels were adjusted for
the typical effect of medication, when lipid levels were based on original unadjusted values,
when individuals taking cholesterol medication were excluded, or when demographics,
health status, and cholesterol medication were controlled. Findings for triglycerides were
somewhat attenuated when analyses adjusted for negative affect, but this could be due to the
correlation between optimism and negative affect. That said, optimism’s association with
HDL cholesterol and triglycerides was evident among individuals with low negative affect.
This suggests that optimism is not merely a proxy for the absence of distress, but exhibits a
monotonic relationship with lipids across the score range. Findings were also maintained for
high-risk cut-points.
Analyses also pointed to several behavioral pathways that can explain part of the observed
association between optimism and a healthier lipid profile. Consistent with past work,
optimism was associated with smoking status, alcohol consumption, dietary intake, and
exercise.1–4 Adding prudent diet and BMI to regression models noticeably attenuated
optimism’s association with HDL cholesterol and triglycerides. This suggests that optimistic
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individuals may be better equipped than their less optimistic peers to meet the challenges of
engaging in healthy behavior and maintaining a healthy BMI.24 However, rather than merely
operating as a proxy for healthy behavior, optimism may serve as a precursor to healthy
behavior by motivating individuals to behave in ways that are consistent with their favorable
expectations for the future. That is, expectations about the effects of a particular behavior
both precede and influence the behavior itself; the expectations surrounding a behavior are
separate from the behavior itself.25,26 Notably, health behaviors and BMI did not explain the
entire association between optimism and lipids, so there are likely other relevant factors for
explaining the optimism-lipid relation. For example, inflammation has been linked with both
optimism27,28 and metabolic dysfunction,29 which hints that optimism may be associated
with lipids through a direct inflammatory pathway.
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A clear limitation of the present investigation is the cross-sectional data. Whether optimism
leads to healthier lipid profiles or whether healthier lipid profiles (and better health in
general) lead to optimism cannot be determined, although optimism was often measured at
least several months prior to lipid profiles. Notably, optimism did not vary substantially
according to whether individuals were taking lipid medications, reducing somewhat the
concern that lipid levels determine optimism. Although we suspect that optimism does in
fact influence lipid levels as an upstream determinant, it is also possible that the association
is bidirectional. Moreover, an unmeasured third variable could also determine both optimism
and lipid profiles. Future prospective and experimental research is needed to more clearly
establish the direction of effects, investigate whether associations differ depending on health
status, and examine whether controlling other measures of ill-being alters findings. Strengths
of the research include a well-validated measure of optimism and objectively-measured
lipids, which limits concerns regarding self-report bias. Additional strengths include the
ability to consider potential confounding and pathway variables. Taken together, this
research suggests that an optimistic outlook is related to a healthier lipid profile. Thus,
considering optimism in the context of lipids may suggest new strategies for prevention and
intervention to improve cardiovascular health.
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FIGURE 1.

The frequency distribution of 990 optimism scores (mean = 23.95, standard deviation =
4.69) with black representing the lowest tertile of optimism (6–22), gray representing the
middle tertile of optimism (23–26), and white representing the highest tertile of optimism
(27–30).
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Distribution of participant characteristics according to level of optimism.a
Characteristic
Percentages or Mean (Standard
Deviation)
Age (years)

Optimism
Low
(n = 334)

Moderate
(n = 300)

High
(n = 356)

53.13 (11.68)

56.58 (12.36)

55.75 (11.15)

Sex

pb

0.0005
0.33

48.50%

44.67%

42.98%

36.08%

29.84%

34.08%

51.50%

55.33%

57.02%

31.79%

30.68%

37.52%

91.62%

95.00%

93.26%

33.15%

30.88%

35.97%

8.38%

5.00%

6.74%

41.79%

22.39%

35.82%

Male

Female
Race

0.24

White

Non-white

NIH-PA Author Manuscript

Education

< 0.0001
5.69%

2.33%

2.53%

54.29%

20.00%

25.71%

26.05%

21.00%

15.17%

42.65%

30.88%

26.47%

32.34%

28.67%

25.56%

37.89%

30.18%

31.93%

35.93%

48.00%

56.74%

25.75%

30.90%

43.35%

Income (US dollars in thousands)

68.11 (54.32)

75.58 (57.97)

85.87 (65.12)

0.0004

Time between assessments (months)

25.91 (14.64)

26.15 (14.73)

26.39 (14.66)

0.91

42.22%

44.00%

41.01%

Less than a high school degree

High school degree

Some college

College degree or more

Chronic conditions

0.74

Yes
33.65%

31.50%

34.84%

57.78%

56.00%

58.99%

33.80%

29.42%

36.78%

No

NIH-PA Author Manuscript

Blood pressure medication

0.64
33.83%

37.00%

33.99%

32.75%

32.17%

35.07%

66.27%

63.00%

66.01%

34.26%

29.30%

36.43%

29.71 (6.60)

28.76 (5.51)

28.91 (5.85)

17.66%

9.00%

7.30%

52.68%

24.11%

23.21%

30.24%

36.33%

31.74%

Yes

No
Body mass index

(kg/m2)

Smoking status

0.10
< 0.0001

Current
Past
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Characteristic
Percentages or Mean (Standard
Deviation)

Optimism
pb

Low
(n = 334)

Moderate
(n = 300)

High
(n = 356)

31.27%

33.75%

34.98%

52.10%

54.67%

60.96%

31.35%

29.55%

39.10%

Alcohol consumption (drinks/day)

1.34 (1.40)

1.10 (1.23)

1.15 (1.39)

0.06

Prudent diet

3.90 (1.45)

4.29 (1.32)

4.51 (1.33)

< 0.0001

74.25%

84.00%

80.62%

31.51%

32.02%

36.47%

25.75%

16.00%

19.38%

Never

Regular exercise

0.008

Yes

No
Negative affect

42.36%

23.65%

33.99%

1.76 (0.61)

1.48 (0.43)

1.35 (0.34)

198.15

195.55

196.08

(38.06)

(38.29)

(37.77)

52.29 (17.64)

53.48 (16.55)

56.26 (18.30)

118.07

114.42

113.74

(35.55)

(35.35)

(34.93)

140.53

137.99

128.47

(86.62)

(88.74)

(70.99)

Total cholesterol

0.65

High density lipoprotein cholesterol

NIH-PA Author Manuscript

Low density lipoprotein cholesterol

Triglyceridesc

< 0.0001

0.01
0.23

0.13

a

Percentages at the top of each cell refer to the column % and percentages at the bottom of each cell refer to the row %.

b

p-values come from χ2 or analysis of variance tests.

c

Prior to log transformation.
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TABLE 2

Correlation coefficients for the association between optimism and participant characteristics (N = 990).

NIH-PA Author Manuscript

Association with Optimism
Participant Characteristic

NIH-PA Author Manuscript

r

p

Age

.18

< 0.0001

Sexa

.02

0.49

Raceb

−.04

0.21

Educationc

.18

< 0.0001

Income

.14

< 0.0001

Time between assessments

.01

0.71

Chronic conditionsd

.003

0.93

Blood pressure medicatione

.03

0.43

Body mass index

−.07

0.03

Smoking statusf

.13

< 0.001

Alcohol consumption

−.07

0.03

Prudent diet

.21

< 0.0001

Regular exerciseg

.06

0.04

Negative affect

−.45

< 0.0001

a

Sex: men = 0, women = 1

b

Race: white = 0, non-white = 1

c

Education: less than high school degree = 1, high school degree = 2, some college = 3, college degree or more = 4

d

Chronic conditions: no = 0, yes = 1

e

Blood pressure medication: no = 0, yes = 1

f

Smoking status: 1 = current smoker, 2 = past smoker, 3 = never smoker

g

Regular exercise: no = 0, yes = 1
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Unstandardized parameter estimates [95% confidence interval] for the association between 1 standard
deviation increase in optimism and lipid levels (N = 990).
Lipids (mg/dL)

Model 1a

Model 2b

Total cholesterol

−0.64 [−3.11, 1.83]

−0.61 [−3.09, 1.86]

High density lipoprotein cholesterol

1.32** [0.28, 2.37]

1.21* [0.18, 2.25]

Low density lipoprotein cholesterol

−1.18 [−3.47, 1.11]

−1.18 [−3.48, 1.11]

Triglycerides (log transformed)

−0.03~ [−0.07, 0.0009]

−0.03~ [−0.06, 0.005]

a

Adjusted for demographics (age, sex, race, education, income, and time between assessments)

b

Adjusted for demographics and health status (chronic conditions and blood pressure medication)

~

p ≤ .10,

*

p ≤ .05,

**

p ≤ .01
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0.53
0.54
0.53
0.50

1.21*
1.17*
1.39**
1.12*
0.64

+ Exercise

+ Smoking status

+ Alcohol consumption

+ Body mass index

+ All pathway variablesb
−52%

−15%

6%

−12%

−9%

−35%

–

%Δ

−0.01

−0.03

−0.03~

−0.03~

−0.03~

−0.02

−0.03~

b

0.02

0.02

0.02

0.02

0.02

0.02

0.02

SE

p ≤ .01

**

p ≤ .05,

*

p ≤ .10,

Adjusted for demographics, prudent diet, exercise, smoking status, alcohol consumption, and body mass index

~

b

−54%

−21%

−4%

.2%

−10%

−32%

–

%Δ

Triglycerides (log transformed)

Adjusted for demographics (age, sex, race, education, income, and time between assessments)

a

0.53

0.86~

+ Prudent diet

0.50

0.53

1.32**

Optimism and demographics

SE

High density lipoprotein cholesterol
b

Predictors

Change in the association between optimism and lipid levels when potential pathway variables were included individually and then all together in Model
1a (N = 990).
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TABLE 5
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Odds ratios [95% confidence interval] for the association between 1 standard deviation increase in optimism
and presence of unhealthy lipid levelsa (N = 990).
Lipids

Model 1b

Model 2c

Total cholesterol

0.89~ [0.78, 1.02]

0.91 [0.79, 1.04]

High density lipoprotein cholesterol

0.86* [0.75, 0.98]

0.88~ [0.76, 1.01]

Low density lipoprotein cholesterol

0.91 [0.79, 1.04]

0.93 [0.81, 1.07]

Triglycerides

0.87* [0.76, 1.00]

0.89~ [0.77, 1.03]

a

Risk of unhealthy lipid levels was defined as cholesterol medication, physician diagnosis of having cholesterol problems, or exceeding
conventional cut-points for unhealthy lipid levels (i.e., total cholesterol ≥240 mg/dL, HDL cholesterol <40 mg/dL for men and <50 mg/dL for
women, LDL cholesterol ≥160 mg/dL, and triglycerides ≥200 mg/dL)

b

Adjusted for demographics (age, sex, race, education, income, and time between assessments)

c

Adjusted for demographics and health status (chronic conditions and blood pressure medication)

~

p ≤ .10,
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*

p ≤ .05
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